Jon McCreary, DPM
Foot & Ankle Surgery · Fort Worth, TXNPI 1225030802
Payments from drug & device makers
Across 53 payments — averaging $76.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$2K
- Smith+Nephew$431
- Bone Support Inc.$292
- Treace Medical Concepts, Inc.$170
- Paratek Pharmaceuticals, Inc.$135
- Musculoskeletal Transplant Foundation Inc.$121
- plus $479 from 15 others
What the payments were for
- Travel & lodging$20%
- Food & beverage$1,75143%
- Education$2,31557%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 3 | $2,441 |
| Smith+Nephew | 18 | $431 |
| Bone Support Inc. | 2 | $292 |
| Treace Medical Concepts, Inc. | 2 | $170 |
| Paratek Pharmaceuticals, Inc. | 7 | $135 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $121 |
| Organogenesis Inc. | 1 | $98 |
| Averitas Pharma Inc. | 2 | $67 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $51 |
| Kerecis Limited | 2 | $37 |
| Amgen | 2 | $36 |
| Stryker | 1 | $36 |
| GRT US Holding, Inc. | 1 | $26 |
| Tactile Systems Technology Inc | 1 | $19 |
| Orthofix Medical, Inc. | 3 | $19 |
| Misonix Inc | 1 | $18 |
| DJO, LLC | 1 | $17 |
| Osiris Therapeutics Inc. | 1 | $15 |
| Sanara Medtech Inc. | 1 | $14 |
| Medtronic | 1 | $14 |
| In2bones USA, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CERAMENTBONE VOID FILLER$292
- CERAMENT G$292
- Grafix PRIME$241
- Grafix CORE$241
- Grafix XC$241
- Grafix PL PRIME$241
- Stravix$241
- Lapiplasty System$158
How this compares
$4,069 in reported general payments places this provider in the 50th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 44 | $562 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 50 | $442 |
| Meloxicam | 131 | $337 |
| Mupirocin | 20 | $240 |
| Methylprednisolone | 31 | $235 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $195 |
| Allopurinol | 21 | $112 |
| Ropinirole Hcl | 12 | $87 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Fort Worth
- William CrawfordFort Worth$98K
- Brent BanksFort Worth$79K
- Richard PollakSan Antonio$6.1M
- Joseph CaporussoMcAllen$6M
- Mark DaltonAustin$4.1M
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Chad HowzeSan Antonio$2.4M
- Graham HamiltonEdinburg$2.1M
- Kevin VarnerHouston$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.